In over half of all prostate cancers, chromosomal rearrangements resulting in the fusion of TMPRSS2, an androgen-regulated gene, and the ETS family transcription factor ERG occur (Sandoval et al. 2018). The gene discussed is ERG; the disease is prostate carcinoma.